UBS Knock-Out ABT/ DE000UH8MXA6 /
18.06.2024 11:19:48 | Изменение-0.080 | Бид18.06.2024 | Предложение18.06.2024 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
1.690EUR | -4.52% | 1.690 Величина цены спроса: 5,000 |
1.740 Величина цены предложения: 5,000 |
Abbott Laboratories | 121.2485 USD | 31.12.2078 | Put |
GlobeNewswire
11:00
Hydrogen Powered Internal Combustion Engines are the Focus of a Live Webinar & White Paper
GlobeNewswire
11:00
Altus Formulation and Spektar Join Forces in New Specialty Company Spektus Pharma
GlobeNewswire
11:00
Future Health Index 2024 global report: Healthcare leaders turn to AI to address critical gaps in pa...
GlobeNewswire
10:30
Flash News: OKX Lists ZKsync's ZK Token on its Perpetual Futures Market, Expanding Trading Options
GlobeNewswire
10:01
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD ...
GlobeNewswire
10:00
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors w...
GlobeNewswire
10:00
FSLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fastly, Inc. Investors with Su...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
Nokia and Google Cloud collaborate to help developers worldwide create 5G applications faster with t...
GlobeNewswire
9:55
Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница